Lu, Fang <br/><br/>
Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?  [electronic resource] 

 -  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie  Feb 2009 
 - 171-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1435-702X 
<br/><br/><label>Standard No.: </label>10.1007/s00417-008-0936-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Aptamers, Nucleotide--pharmacology<br/>Bevacizumab<br/>Choroidal Neovascularization--drug therapy<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Fluorescein Angiography<br/>Injections<br/>Light Coagulation<br/>Macular Degeneration--drug therapy<br/>Ranibizumab<br/>Rats<br/>Rats, Inbred BN<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Vitreous Body